Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page
- Check3 days agoChange DetectedThere are no recorded changes to summarize for this page. The provided data does not include additions or deletions to interpret in context.SummaryDifference0.0%

- Check10 days agoChange DetectedThe record now shows that the study was terminated and results were posted on 2026-04-27. It also adds updated details about the trial design, primary and secondary endpoints, eligibility criteria, and list of locations.SummaryDifference2%

- Check17 days agoChange DetectedThe page footer revision updated from **v3.5.0** to **v3.5.2**.SummaryDifference0.0%

- Check24 days agoChange DetectedUpdated location details: the entry 'Vienna' and 'Vienna, Vienna, Austria, 1090' were replaced with 'Vienna, State of Vienna, Austria, 1090' and an additional 'State of Vienna' designation was added. The previous entries 'Vienna' and 'Vienna, Vienna, Austria, 1090' were removed.SummaryDifference0.2%

- Check39 days agoChange DetectedThe results status changed from 'No Results Posted' to 'Results Submitted'. This indicates that trial results have been submitted and are awaiting posting.SummaryDifference0.0%

- Check46 days agoChange DetectedLocation entry Napoli, Italy, 80131 was changed to Naples, Italy, 80131 in the study locations.SummaryDifference0.1%

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.